117 related articles for article (PubMed ID: 28744636)
21. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
[TBL] [Abstract][Full Text] [Related]
22. Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.
Raicevic G; Najar M; Pieters K; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Tissue Eng Part A; 2012 Jul; 18(13-14):1410-8. PubMed ID: 22429150
[TBL] [Abstract][Full Text] [Related]
23. Effect of immunization with polyvinylpyrrolidone on the counts of stromal precursor cells in bone marrow and spleen of CBA and CBA/N mice and cytokine gene expression in primary cultures of these cells.
Gorskaya UF; Danilova TA; Mezentzeva MV; Shapoval MM; Nesterenko VG
Bull Exp Biol Med; 2012 May; 153(1):64-7. PubMed ID: 22808496
[TBL] [Abstract][Full Text] [Related]
24. Role of toll-like receptors on human adipose-derived stromal cells.
Hwa Cho H; Bae YC; Jung JS
Stem Cells; 2006 Dec; 24(12):2744-52. PubMed ID: 16902195
[TBL] [Abstract][Full Text] [Related]
25. TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling.
He X; Wang H; Jin T; Xu Y; Mei L; Yang J
PLoS One; 2016; 11(3):e0149876. PubMed ID: 26930594
[TBL] [Abstract][Full Text] [Related]
26. Proliferative potential of multipotent mesenchymal stromal cells from human bone marrow.
Zhironkina OA; Shipounova IN; Bigildeev AE; Sats NV; Petinati NA; Drize NI
Bull Exp Biol Med; 2012 Feb; 152(4):543-7. PubMed ID: 22803129
[TBL] [Abstract][Full Text] [Related]
27. In vitro mesenchymal trilineage differentiation and extracellular matrix production by adipose and bone marrow derived adult equine multipotent stromal cells on a collagen scaffold.
Xie L; Zhang N; Marsano A; Vunjak-Novakovic G; Zhang Y; Lopez MJ
Stem Cell Rev Rep; 2013 Dec; 9(6):858-72. PubMed ID: 23892935
[TBL] [Abstract][Full Text] [Related]
28. Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study.
Kim HK; Kim JH; Abbas AA; Yoon TR
Clin Orthop Relat Res; 2009 Dec; 467(12):3121-8. PubMed ID: 18665432
[TBL] [Abstract][Full Text] [Related]
29. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.
Romieu-Mourez R; François M; Boivin MN; Bouchentouf M; Spaner DE; Galipeau J
J Immunol; 2009 Jun; 182(12):7963-73. PubMed ID: 19494321
[TBL] [Abstract][Full Text] [Related]
30. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
Zhao L; Li G; Chan KM; Wang Y; Tang PF
Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
[TBL] [Abstract][Full Text] [Related]
31. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.
Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E
J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells.
Dearman RJ; Cumberbatch M; Maxwell G; Basketter DA; Kimber I
Immunology; 2009 Apr; 126(4):475-84. PubMed ID: 18778283
[TBL] [Abstract][Full Text] [Related]
33. Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells.
Platt MO; Roman AJ; Wells A; Lauffenburger DA; Griffith LG
J Cell Physiol; 2009 Nov; 221(2):306-17. PubMed ID: 19544388
[TBL] [Abstract][Full Text] [Related]
34. Effects of plating density and culture time on bone marrow stromal cell characteristics.
Neuhuber B; Swanger SA; Howard L; Mackay A; Fischer I
Exp Hematol; 2008 Sep; 36(9):1176-85. PubMed ID: 18495329
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles.
Hirayama T; Tamaki Y; Takakubo Y; Iwazaki K; Sasaki K; Ogino T; Goodman SB; Konttinen YT; Takagi M
J Orthop Res; 2011 Jul; 29(7):984-92. PubMed ID: 21308757
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
[TBL] [Abstract][Full Text] [Related]
37. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation.
Oshima N; Ishihara S; Rumi MA; Aziz MM; Mishima Y; Kadota C; Moriyama I; Ishimura N; Amano Y; Kinoshita Y
Clin Exp Immunol; 2010 Feb; 159(2):185-98. PubMed ID: 19912257
[TBL] [Abstract][Full Text] [Related]
38. Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands.
Rumio C; Sommariva M; Sfondrini L; Palazzo M; Morelli D; Viganò L; De Cecco L; Tagliabue E; Balsari A
J Cell Physiol; 2012 Mar; 227(3):1107-13. PubMed ID: 21567398
[TBL] [Abstract][Full Text] [Related]
39. Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development.
Bayyurt B; Tincer G; Almacioglu K; Alpdundar E; Gursel M; Gursel I
J Control Release; 2017 Feb; 247():134-144. PubMed ID: 28069554
[TBL] [Abstract][Full Text] [Related]
40. Insulin resistance and increased lipolysis in bone marrow derived adipocytes stimulated with agonists of Toll-like receptors.
Franchini M; Monnais E; Seboek D; Radimerski T; Zini E; Kaufmann K; Lutz T; Reusch C; Ackermann M; Muller B; Linscheid P
Horm Metab Res; 2010 Sep; 42(10):703-9. PubMed ID: 20603780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
